Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J May

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2011
NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphomaAnita Gaurnier-Hausser, Reema Patel, Albert S Baldwin, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 11, 2005
NFkappaB activates in vivo the synthesis of inducible Cox-2 in the brainAgnès Nadjar, Viviane Tridon, Michael J May, et al.
Biochemical and Biophysical Research Communications|June 20, 2014
Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosisCarolyn M Gray, Kelly A McCorkell, Srinivas K Chunduru, et al.
Immunology|June 15, 2006
Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factorIsabelle G De Plaen, Xin-Bing Han, Xueli Liu, et al.
Stroke|April 19, 2008
A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damageCora H Nijboer, Cobi J Heijnen, Floris Groenendaal, et al.
Arthritis Research & Therapy|May 11, 2006
Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammationSander W Tas, Margriet J Vervoordeldonk, Najat Hajji, et al.
Surgery|September 10, 2002
Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell deathRobert P Thomas, Buckminster J Farrow, Sunghoon Kim, et al.
Stroke|April 19, 2008
Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokinesCora H A Nijboer, Cobi J Heijnen, Floris Groenendaal, et al.
Science Signaling|April 3, 2020
4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signalingBenjamin I Philipson, Roddy S O'Connor, Michael J May, et al.
The Journal of Biological Chemistry|July 12, 2003
Tumor necrosis factor-alpha induces nuclear factor-kappaB-dependent TRPC1 expression in endothelial cellsBiman C Paria, Asrar B Malik, Angela M Kwiatek, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2011
NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphomaAnita Gaurnier-Hausser, Reema Patel, Albert S Baldwin, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 11, 2005
NFkappaB activates in vivo the synthesis of inducible Cox-2 in the brainAgnès Nadjar, Viviane Tridon, Michael J May, et al.
Biochemical and Biophysical Research Communications|June 20, 2014
Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosisCarolyn M Gray, Kelly A McCorkell, Srinivas K Chunduru, et al.
Immunology|June 15, 2006
Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factorIsabelle G De Plaen, Xin-Bing Han, Xueli Liu, et al.
Stroke|April 19, 2008
A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damageCora H Nijboer, Cobi J Heijnen, Floris Groenendaal, et al.
Arthritis Research & Therapy|May 11, 2006
Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammationSander W Tas, Margriet J Vervoordeldonk, Najat Hajji, et al.
Surgery|September 10, 2002
Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell deathRobert P Thomas, Buckminster J Farrow, Sunghoon Kim, et al.
Stroke|April 19, 2008
Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokinesCora H A Nijboer, Cobi J Heijnen, Floris Groenendaal, et al.
Science Signaling|April 3, 2020
4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signalingBenjamin I Philipson, Roddy S O'Connor, Michael J May, et al.
The Journal of Biological Chemistry|July 12, 2003
Tumor necrosis factor-alpha induces nuclear factor-kappaB-dependent TRPC1 expression in endothelial cellsBiman C Paria, Asrar B Malik, Angela M Kwiatek, et al.
Pageof 7